Process development for cross-flow diafiltration-based VLP disassembly: A novel high-throughput screening approach.

cross-flow filtration disassembly downstream processing high-throughput screening virus-like particles

Journal

Biotechnology and bioengineering
ISSN: 1097-0290
Titre abrégé: Biotechnol Bioeng
Pays: United States
ID NLM: 7502021

Informations de publication

Date de publication:
10 2021
Historique:
revised: 09 06 2021
received: 26 03 2021
accepted: 19 06 2021
pubmed: 26 6 2021
medline: 3 3 2022
entrez: 25 6 2021
Statut: ppublish

Résumé

Virus-like particles (VLPs) are particulate structures, which are applied as vaccines or delivery vehicles. VLPs assemble from subunits, named capsomeres, composed of recombinantly expressed viral structural proteins. During downstream processing, in vivo-assembled VLPs are typically dis- and reassembled to remove encapsulated impurities and to improve particle morphology. Disassembly is achieved in a high-pH solution and by the addition of a denaturant or reducing agent. The optimal disassembly conditions depend on the VLP amino acid sequence and structure, thus requiring material-consuming disassembly experiments. To this end, we developed a low-volume and high-resolution disassembly screening that provides time-resolved insight into the VLP disassembly progress. In this study, two variants of C-terminally truncated hepatitis B core antigen were investigated showing different disassembly behaviors. For both VLPs, the best capsomere yield was achieved at moderately high urea concentration and pH. Nonetheless, their disassembly behaviors differed particularly with respect to disassembly rate and aggregation. Based on the high-throughput screening results, a diafiltration-based disassembly process step was developed. Compared with mixing-based disassembly, it resulted in higher yields of up to 0.84 and allowed for integrated purification. This process step was embedded in a filtration-based process sequence of disassembly, capsomere separation, and reassembly, considerably reducing high-molecular-weight species.

Identifiants

pubmed: 34170511
doi: 10.1002/bit.27868
doi:

Substances chimiques

Capsid Proteins 0
Hepatitis B Vaccines 0
Vaccines, Virus-Like Particle 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3926-3940

Informations de copyright

© 2021 The Authors. Biotechnology and Bioengineering published by Wiley Periodicals LLC.

Références

Beynon, R. J., & Easterby, J. S. (1996). Buffer solutions (1st ed.). Oxford University Press Inc. https://doi.org/10.4324/9780203494691
Billaud, J.-N., Peterson, D., Barr, M., Chen, A., Sallberg, M., Garduno, F., Goldstein, P., McDowell, W., Hughes, J., Jones, J., & Milich, D. (2005). Combinatorial approach to hepadnavirus-like particle vaccine design. Journal of Virology, 79(21), 13656-13666. https://doi.org/10.1128/JVI.79.21.13656
Bin Mohamed Suffian, I. F., Garcia-Maya, M., Brown, P., Bui, T., Nishimura, Y., Palermo, A. R., Ogino, C., Kondo, A., & Al-Jamal, K. T. (2017). Yield optimisation of hepatitis B virus core particles in E. coli expression system for drug delivery applications. Scientific Reports, 7(1), 43160. https://doi.org/10.1038/srep43160
Borisova, G., Borschukova, O., Skrastina, D., Dislers, A., Ose, V., Pumpens, P., & Grens, E. (1999). Behavior of a short preS1 epitope on the surface of hepatitis B core particles. Biological Chemistry, 380(3), 315-324. https://doi.org/10.1515/BC.1999.043
Bryan, J. T., Buckland, B., Hammond, J., & Jansen, K. U. (2016). Prevention of cervical cancer: Journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine. Current Opinion in Chemical Biology, 32, 34-47. https://doi.org/10.1016/j.cbpa.2016.03.001
Bull, H. B., Breese, K., Ferguson, G. L., & Swenson, C. A. (1964). The pH of urea solutions. Archives of Biochemistry and Biophysics, 104(2), 297-304. https://doi.org/10.1016/S0003-9861(64)80017-5
Böttcher, B., Vogel, M., Ploss, M., & Nassal, M. (2006). High plasticity of the hepatitis B virus capsid revealed by conformational stress. Journal of Molecular Biology, 356(3), 812-822. https://doi.org/10.1016/j.jmb.2005.11.053
Ceres, P., & Zlotnick, A. (2002). Weak Protein−Protein Interactions Are Sufficient To Drive Assembly of Hepatitis B Virus Capsids. Biochemistry, 41(39), 11525-11531. https://doi.org/10.1021/bi0261645
Chackerian, B. (2007). Virus-like particles: Flexible platforms for vaccine development. Expert Review of Vaccines, 6(3), 381-390. https://doi.org/10.1586/14760584.6.3.381
Crowther, R. A., Kiselev, N. A., Böttcher, B., Berriman, J. A., Borisova, G. P., Ose, V., & Pumpens, P. (1994). Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell, 77(6), 943-950. https://doi.org/10.1016/0092-8674(94)90142-2
Ding, Y., Chuan, Y. P., He, L., & Middelberg, A. P. J. (2010). Modeling the competition between aggregation and self-assembly during virus-like particle processing. Biotechnology and Bioengineering, 107(3), 550-560. https://doi.org/10.1002/bit.22821
Donovan, J. W. (1969). Ultraviolet absorption. In S. J. Leach (Ed.), Physical principles and techniques of protein chemistry (1st ed, pp. 101-170). New York: Academic Press. https://doi.org/10.1016/B978-0-12-440101-3.50009-6
European Medicines Agency. (2015). European public assessment reports: Mosquirix. https://www.ema.europa.eu/en/documents/medicine-outside-eu/mosquirix-summary-public_en.pdf
Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., Appel, R. D., & Bairoch, A. (2005). Protein Identification and analysis tools on the ExPASy server. In J. M. Walker (Ed.), The proteomics protocols handbook (pp. 571-607). Humana Press. https://doi.org/10.1385/1-59259-890-0:571
Gerstweiler, L., Bi, J., & Middelberg, A. (2021). Virus-like particle preparation is improved by control over capsomere-DNA interactions during chromatographic purification. Biotechnology and Bioengineering, 118, 1688-1701. https://doi.org/10.1002/bit.27687
Ghorbani, A., Zare, F., Sazegari, S., Afsharifar, A., Eskandari, M. H., & Pormohammad, A. (2020). Development of a novel platform of virus-like particle (VLP)-based vaccine against COVID-19 by exposing epitopes: An immunoinformatics approach. New Microbes and New Infections, 38, 100786. https://doi.org/10.1016/j.nmni.2020.100786
Hillebrandt, N., Vormittag, P., Bluthardt, N., Dietrich, A., & Hubbuch, J. (2020). Integrated process for capture and purification of virus-like particles: Enhancing process performance by cross-flow filtration. Frontiers in Bioengineering and Biotechnology, 8, 8. https://doi.org/10.3389/fbioe.2020.00489
Holmes, K., Shepherd, D. A., Ashcroft, A. E., Whelan, M., Rowlands, D. J., & Stonehouse, N. J. (2015). Assembly pathway of hepatitis B core virus-like particles from genetically fused dimers. Journal of Biological Chemistry, 290(26), 16238-16245. https://doi.org/10.1074/jbc.M114.622035
Jegerlehner, A. (2002). A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine, 20(25-26), 3104-3112. https://doi.org/10.1016/S0264-410X(02)00266-9
Karpenko, L. I., Ivanisenko, V. A., Pika, I. A., Chikaev, N. A., Eroshkin, A. M., Veremeiko, T. A., & Ilyichev, A. A. (2000). Insertion of foreign epitopes in HBcAg: How to make the chimeric particle assemble. Amino Acids, 18(4), 329-337. https://doi.org/10.1007/s007260070072
Kawahara, K., & Tanford, C. (1966). Viscosity and density of aqueous solutions of urea and guanidine hydrochloride. Journal of Biological Chemistry, 241(13), 3228-3232. https://doi.org/10.1016/S0021-9258(18)96519-1
Kurnik, R. T., Yu, A. W., Blank, G. S., Burton, A. R., Smith, D., Athalye, A. M., & van Reis, R. (1995). Buffer exchange using size exclusion chromatography, countercurrent dialysis, and tangential flow filtration: Models, development, and industrial application. Biotechnology and Bioengineering, 45(2), 149-157. https://doi.org/10.1002/bit.260450209
Layne, E. (1957). Spectrophotometric and turbidimetric methods for measuring proteins. In S. P. Colowick & N. O. Kaplan (Eds.), Methods in enzymology (Vol. 3, pp. 447-454). Academic Press. https://doi.org/10.1016/S0076-6879(57)03413-8
Lee, K. W., & Tan, W. S. (2008). Recombinant hepatitis B virus core particles: Association, dissociation and encapsidation of green fluorescent protein. Journal of Virological Methods, 151(2), 172-180. https://doi.org/10.1016/j.jviromet.2008.05.025
Liew, M. W. O., Chuan, Y. P., & Middelberg, A. P. J. (2012). Reactive diafiltration for assembly and formulation of virus-like particles. Biochemical Engineering Journal, 68, 120-128. https://doi.org/10.1016/j.bej.2012.07.009
Mach, H., Volkin, D. B., Troutman, R. D., Wang, B.B., Luo, Z., Jansen, K. U., & Shi, L. (2006). Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs). Journal of Pharmaceutical Sciences, 95(10), 2195-2206. https://doi.org/10.1002/jps.20696
McAleer, W. J., Buynak, E. B., Maigetter, R. Z., Wampler, D. E., Miller, W. J., & Hilleman, M. R. (1984). Human hepatitis B vaccine from recombinant yeast. Nature, 307(5947), 178-180. https://doi.org/10.1038/307178a0
McCarthy, M. P., White, W. I., Palmer-Hill, F., Koenig, S., & Suzich, J. A. (1998). Quantitative disassembly and reassembly of human papillomavirus type 11 virus-like particles in vitro. Journal of Virology, 72(1), 32-41. https://doi.org/10.1128/JVI.72.1.32-41.1998
Meireles, M., Aimar, P., & Sanchez, V. (1991). Effects of protein fouling on the apparent pore size distribution of sieving membranes. Journal of Membrane Science, 56(1), 13-28. https://doi.org/10.1016/0376-7388(91)85013-U
Nassal, M., Skamel, C., Kratz, P. A., Wallich, R., Stehle, T., & Simon, M. (2005). A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. European Journal of Immunology, 35(2), 655-665. https://doi.org/10.1002/eji.200425449
Newman, M., Chua, P. K., Tang, F.-M., Su, P.-Y., & Shih, C. (2009). Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system. Journal of Virology, 83(20), 10616-10626. https://doi.org/10.1128/JVI.00749-09
Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., & Gray, T. (1995). How to measure and predict the molar absorption coefficient of a protein. Protein Science, 4(11), 2411-2423. https://doi.org/10.1002/pro.5560041120
Phillips, A. T., & Signs, M. W. (2004). Desalting, concentration, and buffer exchange by dialysis and ultrafiltration. Current Protocols in Protein Science, 38(1), 1-15. https://doi.org/10.1002/0471140864.ps0404s38
Porterfield, J. Z., & Zlotnick, A. (2010). A simple and general method for determining the protein and nucleic acid content of viruses by UV absorbance. Virology, 407(2), 281-288. https://doi.org/10.1016/j.virol.2010.08.015
Pumpens, P., & Grens, E. (2001). HBV core particles as a carrier for B cell/T cell epitopes. Intervirology, 44(2-3), 98-114. https://doi.org/10.1159/000050037
Rosenberg, E., Hepbildikler, S., Kuhne, W., & Winter, G. (2009). Ultrafiltration concentration of monoclonal antibody solutions: Development of an optimized method minimizing aggregation. Journal of Membrane Science, 342(1-2), 50-59. https://doi.org/10.1016/j.memsci.2009.06.028
Rüdt, M., Vormittag, P., Hillebrandt, N., & Hubbuch, J. (2019). Process monitoring of virus-like particle reassembly by diafiltration with UV/Vis spectroscopy and light scattering. Biotechnology and Bioengineering, 116(6), 1366-1379. https://doi.org/10.1002/bit.26935
Samandoulgou, I., Hammami, R., Morales Rayas, R., Fliss, I., & Jean, J. (2015). Stability of secondary and tertiary structures of virus-like particles representing noroviruses: Effects of pH, ionic strength, and temperature and implications for adhesion to surfaces. Applied and Environmental Microbiology, 81(22), 7680-7686. https://doi.org/10.1128/AEM.01278-15
Schumacher, J., Bacic, T., Staritzbichler, R., Daneschdar, M., Klamp, T., Arnold, P., Jägle, S., Türeci, Ö., Markl, J., & Sahin, U. (2018). Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide. Journal of Nanobiotechnology, 16(1), 39. https://doi.org/10.1186/s12951-018-0363-0
Shi, L., Sanyal, G., Ni, A., Luo, Z., Doshna, S., Wang, B., Graham, T. L., Wang, N., & Volkin, D. B. (2005). Stabilization of human papillomavirus virus-like particles by non-ionic surfactants. Journal of Pharmaceutical Sciences, 94(7), 1538-1551. https://doi.org/10.1002/jps.20377
Singh, S., & Zlotnick, A. (2003). Observed hysteresis of virus capsid disassembly is implicit in kinetic models of assembly. Journal of Biological Chemistry, 278(20), 18249-18255. https://doi.org/10.1074/jbc.M211408200
Strods, A., Ose, V., Bogans, J., Cielens, I., Kalnins, G., Radovica, I., Kazaks, A., Pumpens, P., & Renhofa, R. (2015). Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications. Scientific Reports, 5(1), 11639. https://doi.org/10.1038/srep11639
van Reis, R., Goodrich, E. M., Yson, C. L., Frautschy, L. N., Whiteley, R., & Zydney, A. L. (1997). Constant Cwall ultrafiltration process control. Journal of Membrane Science, 130(1-2), 123-140. https://doi.org/10.1016/S0376-7388(97)00012-4
van Reis, R., & Zydney, A. L. (2010). Protein ultrafiltration. In M. C. Flickinger (Ed.), Encyclopedia of industrial biotechnology (pp. 1-20). John Wiley & Sons, Inc. https://doi.org/10.1002/9780470054581.eib515
Vormittag, P., Klamp, T., & Hubbuch, J. (2020a). Ensembles of hydrophobicity scales as potent classifiers for chimeric virus-like particle solubility-An amino acid sequence-based machine learning approach. Frontiers in Bioengineering and Biotechnology, 8, 395, 1-15. https://doi.org/10.3389/fbioe.2020.00395
Vormittag, P., Klamp, T., & Hubbuch, J. (2020b). Optimization of a soft ensemble vote classifier for the prediction of chimeric virus-like particle solubility and other biophysical properties. Frontiers in Bioengineering and Biotechnology, 8, 881. https://doi.org/10.3389/fbioe.2020.00881
Yang, Y., Shi, W., Abiona, O. M., Nazzari, A., Olia, A. S., Ou, L., Phung, E., Stephens, T., Tsybovsky, Y., Verardi, R., Wang, S., Werner, A., Yap, C., Ambrozak, D., Bylund, T., Liu, T., Nguyen, R., Wang, L., Zhang, B., … Kwong, P. D. (2021). Newcastle disease virus-like particles displaying prefusion-stabilized SARS-CoV-2 spikes elicit potent neutralizing responses. Vaccines, 9(2), 73. https://doi.org/10.3390/vaccines9020073
Zhang, Y., Liu, Y., Zhang, B., Yin, S., Li, X., Zhao, D., Wang, W., Bi, J., & Su, Z. (2021). In vitro preparation of uniform and nucleic acid free hepatitis B core particles through an optimized disassembly-purification-reassembly process. Protein Expression and Purification, 178, 105747. https://doi.org/10.1016/j.pep.2020.105747
Zhao, Q., Allen, M. J., Wang, Y., Wang, B., Wang, N., Shi, L., & Sitrin, R. D. (2012). Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles. Nanomedicine: Nanotechnology, Biology, and Medicine, 8(7), 1182-1189. https://doi.org/10.1016/j.nano.2012.01.007
Zhao, Q., Modis, Y., High, K., Towne, V., Meng, Y., Wang, Y., Alexandroff, J., Brown, M., Carragher, B., Potter, C. S., Abraham, D., Wohlpart, D., Kosinski, M., Washabaugh, M. W., & Sitrin, R. D. (2012). Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. Virology Journal, 9(1), 52. https://doi.org/10.1186/1743-422X-9-52
Zlotnick, A., Ceres, P., Singh, S., & Johnson, J. M. (2002). A small molecule inhibits and misdirects assembly of hepatitis B virus capsids. Journal of Virology, 76(10), 4848-4854. https://doi.org/10.1128/JVI.76.10.4848-4854.2002
Zlotnick, A., Cheng, N., Conway, J. F., Booy, F. P., Steven, A. C., Stahl, S. J., & Wingfield, P. T. (1996). Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry, 35(23), 7412-7421. https://doi.org/10.1021/bi9604800
Zlotnick, A., Cheng, N., Stahl, S. J., Conway, J. F., Steven, A. C., & Wingfield, P. T. (1997). Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: Implications for morphogenesis and organization of encapsidated RNA. Proceedings of the National Academy of Sciences of the United States of America, 94(18), 9556-9561. https://doi.org/10.1073/pnas.94.18.9556

Auteurs

Nils Hillebrandt (N)

Institute of Engineering in Life Sciences - Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Baden-Württemberg, Germany.

Philipp Vormittag (P)

Institute of Engineering in Life Sciences - Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Baden-Württemberg, Germany.

Annabelle Dietrich (A)

Institute of Engineering in Life Sciences - Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Baden-Württemberg, Germany.

Christina H Wegner (CH)

Institute of Engineering in Life Sciences - Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Baden-Württemberg, Germany.

Jürgen Hubbuch (J)

Institute of Engineering in Life Sciences - Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Baden-Württemberg, Germany.

Articles similaires

Foot-and-Mouth Disease Virus Foot-and-Mouth Disease Egypt Animals Serogroup
Click Chemistry Cell Nucleus DNA Replication Humans DNA, Viral
Human papillomavirus 16 Humans Recombinant Fusion Proteins Molecular Docking Simulation Papillomavirus Infections
Ultrafiltration Silver Animals Metal Nanoparticles Dogs

Classifications MeSH